The primary aim of this study is to assess the efficacy of ejaculatory-sparing HoLEP (ES-HoLEP) in preserving ejaculation while also maintaining good urinary outcomes.
Age
18–100
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
\- Patients who are sexually active with antegrade ejaculation who are undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms.
You may not be if
Patients with pre-existing retrograde ejaculation
Patients who are not sexually active
Patients with indwelling urinary catheter prior to surgery, neurological disease, or history of prior prostatic/urethral surgery that may impact ejaculation
